IGM Biosciences’ $230 Million Public Offering

Wilson Sonsini Goodrich & Rosati advised IGM on the transaction.IGM Biosciences, Inc. announced the pricing of its underwritten public offering of 8,695,653 shares of its non-voting…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here